The exciting field of neuro-repair in multiple sclerosis: an interview with Sarah I Sheikh.
Neurodegener Dis Manag
; 8(1): 13-15, 2018 02.
Article
em En
| MEDLINE
| ID: mdl-29384036
ABSTRACT
Sarah Isabel Sheikh speaks to Laura Dormer, Commissioning Editor Sarah I Sheikh, MD, MSc, MRCP, is a Senior Medical Director in Late Stage Clinical Development at Biogen. Her current focus is on developing therapies for multiple sclerosis/neuroinflammation, remyelination and neuro-repair. Prior to Biogen, Dr Sheikh was an attending in Neurology at Brigham and Women's Hospital. She completed her internship at Massachusetts General Hospital and residency in Neurology and Neuromuscular fellowship at Massachusetts General Hospital and Brigham and Women's Hospital. She received her medical degree from Oxford University Medical School, and a Masters in cell physiology from Oxford University, Corpus Christi College. She is a member of the Royal College of Physicians, London.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Esclerose Múltipla
Tipo de estudo:
Qualitative_research
Limite:
Humans
País/Região como assunto:
America do norte
/
Europa
Idioma:
En
Revista:
Neurodegener Dis Manag
Ano de publicação:
2018
Tipo de documento:
Article
País de afiliação:
Estados Unidos